Switch from Enfuvirtide to Raltegravir in Virologically Suppressed Multidrug‐Resistant HIV‐1–Infected Patients: A Randomized Open‐Label Trial-Reference-Cited by-同舟云学术

Switch from Enfuvirtide to Raltegravir in Virologically Suppressed Multidrug‐Resistant HIV‐1–Infected Patients: A Randomized Open‐Label Trial

Published:2009-10-15 Issue:8 Volume:49 Page:1259-1267
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

De Castro Nathalie,Braun Joséphine,Charreau Isabelle,Pialoux Gilles,Cotte Laurent,Katlama Christine,Raffi François,Weiss Laurence,Meynard Jean‐Luc,Yazdanpanah Yazdan,Delaugerre Constance,Madelaine‐Chambrin Isabelle,Aboulker Jean‐Pierre,Molina Jean‐Michel,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/49/8/1259/1185122/49-8-1259.pdf

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indirect Treatment Comparisons of Lenacapavir Plus Optimized Background Regimen Versus Other Treatments for Multidrug-Resistant Human Immunodeficiency Virus;Value in Health;2022-12

2. HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial;The Lancet HIV;2021-02

3. Ultra-deep sequencing improves the detection of drug resistance in cellular DNA from HIV-infected patients on ART with suppressed viraemia;Journal of Antimicrobial Chemotherapy;2018-08-20

4. Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir;AIDS Research and Human Retroviruses;2017-02

5. Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial;AIDS Research and Therapy;2016-04-02